186 related articles for article (PubMed ID: 3545529)
1. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.
Emerson TE; Fournel MA; Leach WJ; Redens TB
Circ Shock; 1987; 21(1):1-13. PubMed ID: 3545529
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin-III treatment limits disseminated intravascular coagulation in endotoxemia.
Redens TB; Emerson TE
Circ Shock; 1989 May; 28(1):49-58. PubMed ID: 2731321
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.
Emerson TE; Fournel MA; Redens TB; Taylor FB
Am J Med; 1989 Sep; 87(3B):27S-33S. PubMed ID: 2679067
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III replacement in animal models of acquired antithrombin III deficiency.
Emerson TE
Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S37-45; discussion S59-64. PubMed ID: 8186355
[TBL] [Abstract][Full Text] [Related]
5. Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats.
Inoue Y; Kohno S; Miyazaki T; Yamaguchi K
Tohoku J Exp Med; 1991 Mar; 163(3):175-85. PubMed ID: 2063402
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections.
Mertens R; Peschgens T; Granzen B; Heimann G
Klin Padiatr; 1999; 211(2):65-9. PubMed ID: 10407813
[TBL] [Abstract][Full Text] [Related]
8. Choline or CDP-choline attenuates coagulation abnormalities and prevents the development of acute disseminated intravascular coagulation in dogs during endotoxemia.
Yilmaz Z; Ozarda Y; Cansev M; Eralp O; Kocaturk M; Ulus IH
Blood Coagul Fibrinolysis; 2010 Jun; 21(4):339-48. PubMed ID: 20410813
[TBL] [Abstract][Full Text] [Related]
9. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
10. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
[TBL] [Abstract][Full Text] [Related]
12. Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravascular coagulation.
Yao Z; Foster PA; Gross GJ
Circ Shock; 1994 Jul; 43(3):107-14. PubMed ID: 7850930
[TBL] [Abstract][Full Text] [Related]
13. A comparison of haemocoagulation tests in the experimental endotoxin model DIC and in rats whole-body irradiated by 250 Gy.
Hlousková D; Polívková J; Pospísil J; Kase F
Sb Lek; 1993; 94(1):31-8. PubMed ID: 7991995
[TBL] [Abstract][Full Text] [Related]
14. Synergistic protection from lung damage by combining antithrombin-III and alpha 1-proteinase inhibitor in the E. coli endotoxemic sheep pulmonary dysfunction model.
Redens TB; Leach WJ; Bogdanoff DA; Emerson TE
Circ Shock; 1988 Sep; 26(1):15-26. PubMed ID: 3056631
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
16. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
17. [Treatment effects of antithrombin-III on coagulation abnormalities in rats with endotoxaemia].
Qiao YJ; Zhu JM; You XL; Zhang Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):165-7. PubMed ID: 17376272
[TBL] [Abstract][Full Text] [Related]
18. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin-induced intravascular coagulation (DIC) and its therapy.
Prager RL; Dunn EL; Kirsh MM; Penner JA
Adv Shock Res; 1979; 2():277-87. PubMed ID: 400581
[TBL] [Abstract][Full Text] [Related]
20. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis.
Dickneite G; Pâques EP
Thromb Haemost; 1993 Feb; 69(2):98-102. PubMed ID: 8456437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
